News

2018
10/25-28
CMIC will be present at the exhibition booth (#1538) at American Society of Nephrology Kidney Week 2018 in San Diego, USA, from 25th to 28th October 2018.
09/13
New articles related to L-FABP were released.
06/05
New articles related to L-FABP were released.
2017
11/14
New articles related to L-FABP were released.
10/19
CMIC will present an exhibition (#520) at American Society of Nephrology Kidney Week 2017 in New Orleans, USA, from 2nd to 4th November 2017.
10/17
New articles related to L-FABP were released.
2016
11/16-19
CMIC presents at the exhibition booth (#539) at American Society of Nephrology in Chicago, USA.
10/21
CMIC announced release of RENISCHEM® L-FABP POC kit, a newly developed rapid urinary L-FABP test.
 
-L-FABP POC kit reimbursed in Japan and CE marked in EU.
 
-L-FABP ELISA kit with high sensitivity for screening CKD risk reimbursed in Japan and CE marked in EU.
2013
 
-Japanese Society of Nephrology released CKD clinical guideline and L-FABP was introduced as useful CKD biomarker.
 
-ADQI (Acute Dialysis Quality Initiatives) Consensus on AKI Biomarkers and Cardiorenal Syndromoes selected L-FABP as one of the key AKI biomarkers.
2012
 
-L-FABP ELISA kit RESNISCHEMR CE marked, Distribution to Danish market.
 
-KDIGO (Kidney Disease Improving Global Outcomes) selected L-FABP as one of the key biomarkers for AKI diagnosis.
2011
 
-Reimbursement was approved for L-FABP ELISA kit.

Download product leaflet

For nonclinical safety evaluation

Urinary L-FABP kits for Rat, Dog, Cat, Monkey and Pig are available for the purpose of monitoring drug nephrotoxicity and drug effectiveness.
Top ▲ Home ▶